DK131084A - Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel - Google Patents

Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel Download PDF

Info

Publication number
DK131084A
DK131084A DK131084A DK131084A DK131084A DK 131084 A DK131084 A DK 131084A DK 131084 A DK131084 A DK 131084A DK 131084 A DK131084 A DK 131084A DK 131084 A DK131084 A DK 131084A
Authority
DK
Denmark
Prior art keywords
hydrogen
alkyl
egolin
medicine
derivatives
Prior art date
Application number
DK131084A
Other languages
Danish (da)
English (en)
Other versions
DK131084D0 (da
Inventor
Gerhard Sauer
Gregor Haffer
Helmut Wachtel
Herbert Hans Schneider
Wolfgang Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK131084D0 publication Critical patent/DK131084D0/da
Publication of DK131084A publication Critical patent/DK131084A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK131084A 1983-03-14 1984-02-29 Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel DK131084A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3309493A DE3309493A1 (de) 1983-03-14 1983-03-14 Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
DK131084D0 DK131084D0 (da) 1984-02-29
DK131084A true DK131084A (da) 1984-09-15

Family

ID=6193690

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131084A DK131084A (da) 1983-03-14 1984-02-29 Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel

Country Status (11)

Country Link
US (1) US4766128A (cs)
EP (1) EP0118848B1 (cs)
JP (1) JPS59176285A (cs)
AT (1) ATE72667T1 (cs)
AU (1) AU567333B2 (cs)
CA (1) CA1253488A (cs)
CS (1) CS241071B2 (cs)
DE (2) DE3309493A1 (cs)
DK (1) DK131084A (cs)
GR (1) GR81772B (cs)
HU (1) HU191396B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3445784A1 (de) * 1984-12-13 1986-06-26 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von ergolin-derivaten
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
DE3528584A1 (de) * 1985-08-06 1987-02-19 Schering Ag Neue 1-alkyl-ergolin-thioharnstoffderivate
DE3533672A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-substituierte ergolinderivate
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3535929A1 (de) * 1985-10-04 1987-04-09 Schering Ag 1,2-disubstituierte ergolinderivate
DE3535930A1 (de) * 1985-10-04 1987-04-09 Schering Ag Neue 2-substituierte ergolinderivate
DE3623503A1 (de) * 1986-07-09 1988-01-21 Schering Ag 1-aryl-ergolinyl-harnstoffderivate, verfahren zu deren herstellung sowie die verwendung dieser verbindungen als arzneimittel
DE3806374A1 (de) * 1988-02-25 1989-09-07 Schering Ag Neue ergolin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
RU2131427C1 (ru) * 1992-12-24 1999-06-10 Фармация Энд Апджон С.П.А. Производные эрголина, способ их получения, фармацевтическая композиция

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278401A (cs) * 1961-05-29
DE1910930A1 (de) * 1968-03-07 1969-10-16 Farmaceutici Italia Verfahren zur Herstellung von neuen 1,6-Dimethyl-10alpha-ergolinderivaten
JPS4524785Y1 (cs) * 1968-04-20 1970-09-29
DK140596B (da) * 1971-05-19 1979-10-08 Sandoz Ag Analogifremgangsmåde til fremstilling af 8beta-(ureidomethyl)-ergolenderivater.
CH573937A5 (cs) * 1971-08-05 1976-03-31 Spofa Vereinigte Pharma Werke
US3992385A (en) * 1975-01-20 1976-11-16 Eli Lilly And Company 2,3-Dihydroergolines
DE2924102A1 (de) * 1979-06-13 1980-12-18 Schering Ag Neue (ergolin-yl)-n'.n'-diaethylharnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3205169A1 (de) * 1981-02-24 1982-10-14 Sandoz-Patent-GmbH, 7850 Lörrach Neue ergolinderivate, deren herstellung und deren pharmazeutische zusammensetzungen
DE3135305C2 (de) * 1981-09-03 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
CS231214B1 (en) * 1982-03-12 1984-10-15 Antonin Cerny Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea

Also Published As

Publication number Publication date
CS241071B2 (en) 1986-03-13
EP0118848B1 (de) 1992-02-19
EP0118848A2 (de) 1984-09-19
AU2560684A (en) 1984-09-20
DK131084D0 (da) 1984-02-29
ATE72667T1 (de) 1992-03-15
CA1253488A (en) 1989-05-02
EP0118848A3 (en) 1985-12-04
US4766128A (en) 1988-08-23
CS170784A2 (en) 1985-06-13
DE3309493A1 (de) 1984-09-20
HU191396B (en) 1987-02-27
DE3485512D1 (de) 1992-03-26
GR81772B (cs) 1984-12-12
AU567333B2 (en) 1987-11-19
JPS59176285A (ja) 1984-10-05

Similar Documents

Publication Publication Date Title
DK131084A (da) Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel
ATE76069T1 (de) 5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung.
EP0261539A3 (en) Substituted phenyl-sulphon amides
ZA845160B (en) Derivatives of 2.azabicyclo(3.1.0)hexane-3-carboxylic acid,a process for their preparation,agents containing them and their use,and 2-azabicyclo(3.1.0)hexane derivatives as intermediates,and a process for their preparation
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
SE8703854D0 (sv) Prostaglandinderivat for behandling av glaukom eller okuler hypertension
ATE70533T1 (de) Imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3688397D1 (de) 3-(2-aminoethyl)indol und -indolinderivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
NO872875L (no) Modifisert vevsplasminaktivator, samt fremgangsmŸte for fremstilling av en slik.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
AU7720587A (en) Substituted hexahydroarylquinolizines
EP0313945A3 (de) Mittel zur Behandlung des Bluthochdrucks und der Herzinsuffizienz
EP0118564A4 (en) 4-amino-tetrahydro-2-naphthoic acid derivatives.
DK74184A (da) Anti-angina-middel
CS548987A2 (en) Process for preparing new tetracycline derivatives of indole
DE3788888D1 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.
IT8619931A0 (it) Procedimento per la preparazione della 1-(n-metilamidino)-3-(2,6-dimetilfe nil) urea e dei suoi sali farmaceuticamente accettabili.
ATE88636T1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augenhypertension und glaukom.
NO883223L (no) Middel og fremgangsmaate for oxyderende farving av haar med3-(2',2', 2'-trifluorethyl)aminofenolderivater.
ATE100803T1 (de) Perhydrothiazepin- und perhydroazepinderivate, ihre herstellung und ihre therapeutische verwendung.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment